Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Isoproterenol attenuates the thrombin-induced increase in pulmonary endothelial permeability

Conference · · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
OSTI ID:5508387
The proposed permeability-decreasing effect of the beta-agonist, isoproterenol, was tested by measurement of the clearance rate of /sup 125/I-albumin across bovine pulmonary artery endothelial cell monolayers. These cells were seeded on gelatinized polycarbonate filters and mounted in a modified Boyden chamber with Dulbecco's Modified Eagle Medium (DMEM) and 1% BSA in the luminal and abluminal chambers. Baseline clearance rates were measured for an initial 30 min with the cells incubated at 37/sup 0/C in DMEM. At 30 min, 70 ul of either DMEM, ..cap alpha..-thrombin (10/sup -6/M), ..cap alpha..-thrombin and isoproterenol (10/sup -6/M) or isoproterenol alone was added to the luminal chamber. Clearance rates were determined at 30-60 min in each group and normalized to the baseline clearance rates of each (n = 8) cell monolayer. The experimental/baseline values were 0.98 +/- 0.08 (mean +/- SEM) for DMEM, 1.90 +/- 0.10 for thrombin, 1.52 +/- 0.08 for thrombin and isoproterenol, and 0.83 +/- 0.10 for isoproterenol alone. Thrombin increased (p < 0.05) the clearance rate from the control DMEM value and isoproterenol reduced (p < 0.05) the response to thrombin. Therefore, isoproterenol attenuates the thrombin-induced increase in pulmonary endothelial permeability.
Research Organization:
Albany Medical College, NY
OSTI ID:
5508387
Report Number(s):
CONF-8604222-
Conference Information:
Journal Name: Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) Journal Volume: 45:3
Country of Publication:
United States
Language:
English